Fig. 2From: Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosisComparison of the therapeutic effect of UCMSCs among different observation weeks in the liver cirrhosis group. ALT, alanine aminotransferase; AST, glutamic-oxaloacetic transaminase; TBIL, total bilirubin; PTA, prothrombin time activity; MELD, model for end-stage liver diseaseBack to article page